The Efficacy of Single-Dose Intravitreal Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-VEGF Therapy: Real-Life Results

OBJECTIVES: To investigate the efficacy, safety, and side effect profiles of a single-dose intravitreal dexamethasone implant (IDI, Ozurdex) in patients with diabetic macular edema (DME) refractory to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: This study included 101 eyes of 78...

Descripción completa

Detalles Bibliográficos
Autores principales: Simsek, Mert, Citirik, Mehmet, Ozates, Serdar, Tekin, Kemal, Ozkoyuncu, Dilara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784452/
https://www.ncbi.nlm.nih.gov/pubmed/35098061
http://dx.doi.org/10.14744/bej.2020.06977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784452/
https://www.ncbi.nlm.nih.gov/pubmed/35098061
http://dx.doi.org/10.14744/bej.2020.06977

Ejemplares similares